Nov 18, 2021 | CanaudLab EN
In October 14-15, the team participated to the “TOR de France” conference. Guillaume Canaud delivered a lecture on new developments for PIK3CA-Related overgrowth spectrom and the team presented a poster on the Impact of PIK3CA Gain-of-function mutation in...
Oct 19, 2021 | CanaudLab EN
PROS is a spectrum of rare disorders caused by PIK3CA mutations and is characterized by atypical, visible overgrowths and anomalies in blood vessels, the lymphatic system and other tissues At 24 weeks, 38% of patients achieved ≥20% reduction in the volume of the...
Oct 19, 2021 | CanaudLab EN
The team of Professor Guillaume Canaud of the adult nephrology-renal transplantation department of the Necker-Enfants Malades AP-HP hospital, has been very involved for several years in the management of patients with dysharmonious hypergrowth syndrome (PIK3CA-Related...
Oct 6, 2021 | CanaudLab EN
The team from the adult nephrology-renal transplantation department of the Necker-Enfants Malades AP-HP hospital, Inserm and the University of Paris has carried out work, coordinated by Prof. Guillaume Canaud, which opens up new perspectives. therapies for patients...
Jul 12, 2021 | CanaudLab EN
The “GAGNA A. & CH. VAN HECK PRIZE FOR INCURABLE DISEASES – 2021” has been awarded to Professor Guillaume CANAUD, from the Necker Hospital, University of Paris (France), for his contributions to the therapy of a spectrum of overgrowth syndromes...
